Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
"CLR 131 multiple myeloma" - Google News
Get the latest updates from "CLR 131 multiple myeloma" - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 2 years ago
A genome-scale screen for synthetic drivers of T cell proliferation - Nature.com
about 2 years ago
A genome-scale screen for synthetic drivers of T cell proliferation Nature.com
Short Interest in Cellectar Biosciences, Inc. (NASDAQ:CLRB) Drops By 43.1% - MarketBeat
about 2 years ago
Short Interest in Cellectar Biosciences, Inc. (NASDAQ:CLRB) Drops By 43.1% MarketBeat
Cellectar Biosciences (NASDAQ:CLRB) Now Covered by StockNews.com - MarketBeat
about 2 years ago
Cellectar Biosciences (NASDAQ:CLRB) Now Covered by StockNews.com MarketBeat
Cellectar Biosciences (NASDAQ:CLRB) Now Covered by Analysts at StockNews.com - MarketBeat
about 2 years ago
Cellectar Biosciences (NASDAQ:CLRB) Now Covered by Analysts at StockNews.com MarketBeat
Cellectar Biosciences (NASDAQ:CLRB) Research Coverage Started at StockNews.com - MarketBeat
about 2 years ago
Cellectar Biosciences (NASDAQ:CLRB) Research Coverage Started at StockNews.com MarketBeat
Cellectar Biosciences : Corporate Presentation - February 2022 - marketscreener.com
over 2 years ago
Cellectar Biosciences : Corporate Presentation - February 2022 marketscreener.com
Blood & Marrow Transplant Outcomes Exceed Expectations - OncLive
over 2 years ago
Blood & Marrow Transplant Outcomes Exceed Expectations OncLive
Ramchandren Reviews the Rationale to Further Evaluate CLR 131 in Waldenström Macroglobulinemia - OncLive
over 2 years ago
Ramchandren Reviews the Rationale to Further Evaluate CLR 131 in Waldenström Macroglobulinemia...
Bone Cancer Treatment Market Report Shows Increasing Demand Due to the High Adoption and Changing Consumer - EIN News
over 2 years ago
Bone Cancer Treatment Market Report Shows Increasing Demand Due to the High...
Short Interest in Cellectar Biosciences, Inc. (NASDAQ:CLRB) Expands By 138.8% - MarketBeat
over 2 years ago
Short Interest in Cellectar Biosciences, Inc. (NASDAQ:CLRB) Expands By 138.8% MarketBeat
M. Eileen Dolan Named Deputy Director of the University of Chicago Medicine Comprehensive Cancer Center - OncLive
over 2 years ago
M. Eileen Dolan Named Deputy Director of the University of Chicago Medicine...
Idecabtagene Vicleucel Approved in Japan for Relapsed/Refractory Multiple Myeloma - OncLive
over 2 years ago
Idecabtagene Vicleucel Approved in Japan for Relapsed/Refractory Multiple Myeloma OncLive